Abstract
Millions of individuals older than 50-years suffer from age-related macular degeneration (AMD). Associated with this multifactorial disease are polymorphisms of complement factor genes and a main environmental risk factor—oxidative stress. Until now the linkage between these risk factors for AMD has not been fully understood. Recent studies, integrating results on oxidative stress, complement activation, epidemiology and ocular pathology suggested the following sequence in AMD-etiology: initially, chronic oxidative stress results in modification of proteins and lipids in the posterior of the eye; these tissue alterations trigger chronic inflammation, involving the complement system; and finally, invasive immune cells facilitate pathology in the retina. Here, we summarize the results for animal studies which aim to elucidate this molecular interplay of oxidative events and tissue-specific complement activation in the eye.
Luciana M. Pujol-Lereis and Nicole Schäfer both have contributed equally to the study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson DH, Radeke MJ, Gallo NB et al (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29:95–112
Beattie JR, Pawlak AM, Boulton ME et al (2010) Multiplex analysis of age-related protein and lipid modifications in human Bruch’s membrane. FASEB J 24:4816–4824
Begum R, Powner MB, Hudson N et al (2013) Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS One 8:e57828
Birari R, Villegas L, Locke J et al (2012) Conditional knock down of SOD3 in smooth muscle cells augments chronic hypoxic pulmonary vascular remodeling and inflammation. Am J Respir Crit Care Med 185.1_MeetingAbstracts.A4742
Bora NS, Gobleman CL, Atkinson JP et al (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34:3579–3584
Coffey PJ, Gias C, McDermott CJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci USA 104:16651–16656
Cruz-Guilloty F, Saeed A, Echegaray J et al (2013) Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflam 2013:503725
Ebrahem Q, Renganathan K, Sears J et al (2006) Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc Natl Acad Sci U S A 103:13480–13484
Faber C, Williams J, Juel HB et al (2012) Complement factor H deficiency results in decreased neuroretinal expression of Cd59a in aged mice. Invest Ophthalmol Vis Sci 53:6324–6330
Hadziahmetovic M, Dentchev T, Song Y et al (2008) Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49:2728–2736
Hadziahmetovic M, Kumar U, Song Y et al (2012a) Microarray analysis of murine retinal light damage reveals changes in iron regulatory, complement, and antioxidant genes in the neurosensory retina and isolated RPE. Invest Ophthalmol Vis Sci 53:5231–5241
Hadziahmetovic M, Pajic M, Grieco S et al (2012b) The oral iron chelator deferiprone protects against retinal degeneration induced through diverse mechanisms. Transl Vis Sci Technol 1:2
Hollyfield JG, Bonilha VL, Rayborn ME et al (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14:194–198
Imamura Y, Noda S, Hashizume K et al (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 103:11282–11287
Joseph K, Kulik L, Coughlin B et al (2013) Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner. J Biol Chem 288:12753–12765
Kew RR, Ghebrehiwet B, Janoff A (1985) Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 75:1000–1007
Khan JC, Thurlby DA, Shahid H et al (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90:75–80
Mao H, Seo SJ, Biswal MR et al (2014) Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration. Invest Ophthalmol Vis Sci 55:4613–4627
Pickering MC, Cook HT, Warren J et al (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31:424–428
Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8:582–587
Radu RA, Hu J, Yuan Q et al (2011) Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J Biol Chem 286:18593–18601
Rohrer B, Guo Y, Kunchithapautham K et al (2007) Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Invest Ophthalmol Vis Sci 48:5282–5289
Rutar M, Natoli R, Kozulin P et al (2011) Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia/macrophages is associated with focal photoreceptor degeneration. Invest Ophthalmol Vis Sci 52:5347–5358
Rutar M, Natoli R, Albarracin R et al (2012) 670-nm light treatment reduces complement propagation following retinal degeneration. J Neuroinflammation 9:257
Schütt F, Davies S, Kopitz J et al (2000) Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 41:2303–2308
Schutt F, Bergmann M, Holz FG et al (2003) Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 44:3663–3668
Seo S, Krebs MP, Mao H et al (2012) Pathological consequences of long-term mitochondrial oxidative stress in the mouse retinal pigment epithelium. Exp Eye Res 101:60–71
Sohn JH, Kaplan HJ, Suk HJ et al (2000) Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 41:3492–3502
Song D, Song Y, Hadziahmetovic M et al (2012) Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radic Biol Med 53:64–71
Wang AL, Lukas TJ, Yuan M et al (2009) Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration. PLoS One 4:e5304
Weismann D, Hartvigsen K, Lauer N et al (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76–81
Williams JAE, Greenwood J, Moss SE (2013) Retinal changes precede visual dysfunction in the complement factor H knockout mouse. PLoS One 8:e68616
Woodell A, Coughlin B, Kunchithapautham K et al (2013) Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury. PLoS One 8:e67894
Zhao Z, Chen Y, Wang J et al (2011) Age-related retinopathy in NRF2-deficient mice. PLoS One 6:e19456
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this paper
Cite this paper
Pujol-Lereis, L., Schäfer, N., Kuhn, L., Rohrer, B., Pauly, D. (2016). Interrelation Between Oxidative Stress and Complement Activation in Models of Age-Related Macular Degeneration. In: Bowes Rickman, C., LaVail, M., Anderson, R., Grimm, C., Hollyfield, J., Ash, J. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 854. Springer, Cham. https://doi.org/10.1007/978-3-319-17121-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-17121-0_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17120-3
Online ISBN: 978-3-319-17121-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)